According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...

Deerfield, Illinois, Feb. 27, 2025 (GLOBE NEWSWIRE) -- DEERFIELD, IL. February 27, 2025 – Vantage Specialty Chemicals, Inc., (Vantage) today announced that its VYCERIN™ API Glycerin, USP is listed on ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

(MENAFN- Market Press Release) August 20, 2023 9:42 pm - When designing pharmaceutical preparations, the choice of excipients should not only consider the dosage form factors and excipient functions ...

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience ...

Inhaled drug formulation involves consideration of multiple factors, including the properties of the API, the needs of the target patient population, the delivery requirements, and the choice of ...

Halo Pharma becomes a standalone drug product CDMO after the sale of Noramco’s API assets, adding sterile services by H2 2026 ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...

Pharmaceutical companies are increasingly focusing on acquisitions in the Active Pharmaceutical Ingredients (API) and formulation space to consolidate market share and diversify portfolios, global ...

DUBLIN, May 10, 2021 /PRNewswire/ -- The "Global Active Pharmaceutical Ingredient Market (2020-2025) by Type, Molecule, Product Type, Formulation Type, Manufacturing Type, Synthesis Type, Drug Type, ...

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland)The ...